These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1310680

  • 1. Structure function analysis of vitamin D analogs with C-ring modifications.
    Bouillon R, Allewaert K, van Leeuwen JP, Tan BK, Xiang DZ, De Clercq P, Vandewalle M, Pols HA, Bos MP, Van Baelen H.
    J Biol Chem; 1992 Feb 15; 267(5):3044-51. PubMed ID: 1310680
    [Abstract] [Full Text] [Related]

  • 2. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW, Bouillon R, Farach-Carson MC, Bishop JE, Zhou LX, Nemere I, Zhao J, Muralidharan KR, Okamura WH.
    J Biol Chem; 1993 Sep 25; 268(27):20022-30. PubMed ID: 8397195
    [Abstract] [Full Text] [Related]

  • 3. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 4. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
    Inaba M, Okuno S, Nishizawa Y, Yukioka K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):421-5. PubMed ID: 2823715
    [Abstract] [Full Text] [Related]

  • 5. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW, Okamura WH, Farach-Carson MC, Allewaert K, Branisteanu D, Nemere I, Muralidharan KR, Bouillon R.
    J Biol Chem; 1993 Jul 05; 268(19):13811-9. PubMed ID: 8390978
    [Abstract] [Full Text] [Related]

  • 6. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.
    Binderup L, Bramm E.
    Biochem Pharmacol; 1988 Mar 01; 37(5):889-95. PubMed ID: 2830885
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R, Allewaert K, Xiang DZ, Tan BK, van Baelen H.
    J Bone Miner Res; 1991 Oct 01; 6(10):1051-7. PubMed ID: 1796753
    [Abstract] [Full Text] [Related]

  • 8. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP.
    Blood; 1989 Jul 01; 74(1):82-93. PubMed ID: 2665845
    [Abstract] [Full Text] [Related]

  • 9. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
    Honda A, Nakashima N, Mori Y, Katsumata T, Ishizuka S.
    J Steroid Biochem Mol Biol; 1992 Jan 01; 41(1):109-12. PubMed ID: 1310414
    [Abstract] [Full Text] [Related]

  • 10. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR, Prahl JM, Smith CM, DeLuca HF.
    J Med Chem; 1998 Nov 05; 41(23):4662-74. PubMed ID: 9804706
    [Abstract] [Full Text] [Related]

  • 11. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
    Bouillon R, Sarandeses LA, Allewaert K, Zhao J, Mascareñas JL, Mouriño A, Vrielynck S, de Clercq P, Vandewalle M.
    J Bone Miner Res; 1993 Aug 05; 8(8):1009-15. PubMed ID: 8213251
    [Abstract] [Full Text] [Related]

  • 12. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP.
    Leuk Res; 1994 Jun 05; 18(6):453-63. PubMed ID: 8207963
    [Abstract] [Full Text] [Related]

  • 13. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
    Zhou JY, Norman AW, Akashi M, Chen DL, Uskokovic MR, Aurrecoechea JM, Dauben WG, Okamura WH, Koeffler HP.
    Blood; 1991 Jul 01; 78(1):75-82. PubMed ID: 1648977
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar 01; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3.
    Hara N, Eguchi T, Ikekawa N, Ishizuka S, Sato J.
    J Steroid Biochem; 1990 May 01; 35(6):655-64. PubMed ID: 2163469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.